You are here: Home » News-CM » Companies » Results
Business Standard

Kilitch Drugs (India) standalone net profit declines 36.71% in the December 2019 quarter

Capital Market 

Sales decline 6.16% to Rs 18.14 crore

Net profit of Kilitch Drugs (India) declined 36.71% to Rs 2.19 crore in the quarter ended December 2019 as against Rs 3.46 crore during the previous quarter ended December 2018. Sales declined 6.16% to Rs 18.14 crore in the quarter ended December 2019 as against Rs 19.33 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales18.1419.33 -6 OPM %12.1323.33 -PBDT3.084.84 -36 PBT2.704.53 -40 NP2.193.46 -37

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, February 15 2020. 11:00 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU